Our company and Suzhou yusen new drug development co., ltd. held a signing ceremony for the research and development project of 1.1 kinds of innovative traditional Chinese medicine Weiling zhenjin gel patch

On June 19, 2023, Guizhou Ruihe Pharmaceutical Co., Ltd. and Suzhou Yusen New Drug Development Co., Ltd. signed a contract for the 1.1 class of traditional Chinese medicine innovative medicine Weiling Shenjin Gel patch project in Guizhou Ruihe Pharmaceutical Co., Ltd.

Xuan Zhenyu, founder of Suzhou Yusen New Drug Development Co., Ltd., Tong Xiaojing, manager of the Ministry of Commerce, Xiong Yigang, chairman of Guizhou Ruihe Pharmaceutical Co., Ltd., Zhao Yun, general manager, Chen Yuyou, secretary of the board of directors, Zhang Yun, deputy general manager, Lu Jintian, director of the operation department, and He Feng, director of the research and development department, attended the signing ceremony.

Suzhou Yusen New Drug Development Co., Ltd. has a whole industry chain technology innovation platform such as early discovery, research and development and pilot production of new drugs of traditional Chinese medicine. In view of the advantages of traditional Chinese medicine treatment, in-depth exploration and innovation, research and development to provide new drug products with clinical application value, and provide high-quality and efficient one-stop service for the development of new traditional Chinese medicine. Guizhou Ruihe Pharmaceutical Co., Ltd. has the strength and channels to promote the commercialization and industrialization of drugs. The two sides reached a cooperation agreement to cooperate in the development of 1.1 categories of Chinese medicine innovation drug Weiling Shenjin gel patch project. The two sides discussed the current research and development progress of Weiling Shenjin Gel patch, the transformation of later projects, especially the design of later clinical development and the selection of indications. In addition, the two sides conducted in-depth exchanges on the current situation of the development of traditional Chinese medicine in China, the same prescription medicine with the same name, and the compound preparation of traditional Chinese medicine with ancient classic prescriptions.

The research and development of Weiling extensor gel patch will help enrich the company's product structure and have a significant impact on the future product strategic layout. The two sides jointly adhere to the principle of "equality and mutual benefit, mutual cooperation and common development", give full play to their respective advantages, expand cooperation areas, innovate cooperation models, develop innovative drugs of traditional Chinese medicine, and strive to achieve "win-win cooperation in scientific innovation and production and research".

Finally, Chairman Xiong once again expressed his gratitude to Mr. Xuan, Mr. Tong and his party, and said that he would further strengthen corporate exchanges and cooperation, give full play to the advantages of both parties, and continue to cooperate in the development of innovative Chinese medicine drugs, drugs with the same name and ancient classics on the basis of strategic cooperation. Traditional Chinese medicine compound preparation.